GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4922)

  • GC72418 structure
    GC72418Inolimomab
    CAS: 152981-31-2
    Purity: >98.00%

    Inolimomab est un anticorps monoclonal à chaîne α récepteur anti-interleukine-2 (IL-2R).

  • GC72424 structure
    GC72424Lutikizumab
    CAS: 1791411-57-8
    Purity: >96.00%

    Lutikizumab (ABT-981) est une immunoglobuline à double domaine variable anti-IL-1α et IL-1β.

  • GC72426 structure
    GC72426Manfidokimab
    CAS: 2428381-56-8
    Purity: 95.00%

    Manfidokimab (AK120) est un anticorps monoclonal alpha (IL-4Rα) IgG4 récepteur anti-interleukine 4.

  • GC72428 structure
    GC72428Melrilimab
    CAS: 2222865-46-3
    Purity: >96.00%

    Melrilimab (GSK 3772847) est un anticorps monoclonal igg2κ anti - il1rl1 / ST2 / il33r / der4 / fit - 1.

  • GC72429 structure
    GC72429Mirikizumab
    CAS: 1884201-71-1
    Purity: >98.00%

    Mirikizumab (ly3074828) est un anticorps monoclonal humanisé igg4 qui cible la Sous - unité p19 de l'interleukine 23.

  • GC72433 structure
    GC72433Nemvaleukin alfa
    CAS: 2315268-27-8
    Purity: >99.00%

    Nemvaleukin alfa (ALKS 4230) est une protéine de fusion IL-2 qui se lie sélectivement à l’il-2r d’affinité intermédiaire.

  • GC72456 structure
    GC72456Eblasakimab
    CAS: 2445460-16-0
    Purity: >99.00%

    Eblasakimab (ASLAN004; CSL-334) est un anticorps IgG4 humain qui cible spécifiquement IL13RA1 et est principalement exprimé par les cellules CHO-K1.

  • GC72471 structure
    GC72471Remtolumab
    CAS: 1791410-27-9
    Purity: >99.00%

    Remtolumab (ABT-122) est une immunoglobuline à domaine double variable qui neutralise à la fois le facteur de nécrose tumorale α (TNFα) et l’il-17a.

  • GC72473 structure
    GC72473Crovalimab
    CAS: 1917321-26-6
    Purity: >98.00%

    Crovalimab(sky59; ro7112689) est un nouvel anticorps humanisé C5 dépendant du pH avec une KD de 15,2 nm et 16,8 µm à pH 7,4 et 5,8, respectivement.

  • GC72511 structure
    GC72511L-Cystathionine dihydrochloride
    CAS: 61125-50-6
    Purity: >99.50%

    L-Cystathionine dihydrochloride est un thioéther non protéique et est un acide aminé clé associé à l’état métabolique des acides aminés contenant du soufre.

  • GC72573 structure
    GC72573Sodium 2-oxopropanoate-13C
    CAS: 124052-04-6
    Purity: >98.50%

    Sodium 2-oxopropanoate-13C est le 2-oxopropanoate de Sodium étiqueté 13C.

  • GC72574 structure
    GC725742-Oxopropanoate-13C5 sodium
    CAS: 89196-78-1

    2-Oxopropanoate-13C5 sodium est le 2-oxopropanoate de Sodium étiqueté 13C.

  • GC72575 structure
    GC72575L-Glutamic acid monosodium (hydrate)
    CAS: 6106-04-3
    Purity: >98.00%

    L-Glutamic acid monosodium (hydrate) est un additif nutritionnel et agent aromatisant.

  • GC72610 structure
    GC72610Cartap hydrochloride
    CAS: 15263-52-2
    Purity: >90.00%

    Cartap hydrochloride un insecticide organique azoté qui peut provoquer des contractures apparemment irréversibles et dépendantes du calcium dans les muscles diaphragmatiques isolés de souris et de lapins.

  • GC72755 structure
    GC72755Tempol-d17,15N
    CAS: 90429-66-6

    Tempol-d17,15N est le deutérium marqué Tempol.

  • GC72757 structure
    GC72757SPC 839
    CAS: 219773-55-4
    Purity: >99.00%

    SPC 839 (composé 10) est un inhibiteur oral actif de l’activation transcriptionnelle médiée par AP-1 et NF-kB avec une ci50 de 0,008 μM.

  • GC72791 structure
    GC72791Delmitide acetate
    CAS: 501019-16-5
    Purity: >98.00%

    Delmitide acetate est un décapeptide D - isomère actif par voie orale qui possède une forte activité anti - inflammatoire.

  • GC72792 structure
    GC72792Cyclopentenylcytosine
    CAS: 90597-22-1
    Purity: >99.00%

    Cyclopentenylcytosine (CPC) est un analogue nucléosidique qui réduit les niveaux de Cytidine triphosphate (CTP) et de Désoxycytidine triphosphate (dctp) dans les cellules leucémiques en inhibant la CTP synthase.

  • GC72803 structure
    GC72803Aspidin BB
    CAS: 584-28-1
    Purity: >98.00%

    Aspidin BB est un dérivé du phloroglucinol, qui peut être isolé de la partie aérienne de Dryopteris championii.

  • GC72817 structure
    GC72817BAI1 hydrochloride
    CAS: 329349-20-4
    Purity: >99.00%

    BAI1 hydrochloride est un facteur sélectif d’apoptose BAX inhibiteurs allostériques.

  • GC72824 structure
    GC72824KX2-361
    CAS: 897016-26-1
    Purity: >99.00%

    KX2-361 (KX-02) est un inhibiteur de polymérisation Src-kinase et tubuline.

  • GC72826 structure
    GC72826CB7993113
    CAS: 819827-50-4
    Purity: >98.00%

    CB7993113 est un puissant antagoniste AHR, avec une ci50 de 0,33 μM.

  • GC72835 structure
    GC72835NSC260594
    CAS: 906718-66-9
    Purity: >96.00%

    NSC260594 induit l’apoptose.

  • GC72851 structure
    GC72851Belapectin
    CAS: 1980787-47-0
    Purity: >99.00%

    Belapectin (GR - MD - 02) est un inhibiteur de la galactocoaguline - 3 (Gal - 3).